Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 26-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of Chronic Idiopathic Constipation (CIC) in Adults

NCT07382167 is registered in ClinicalTrials.gov with Ardelyx as lead sponsor.

NCT NCT07382167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07382167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 26-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of Chronic Idiopathic Constipation (CIC) in Adults
Lead sponsor
Ardelyx
Phase
Phase 3
Overall status
Recruiting
Start date
January 13, 2026
Completion date
June 4, 2027
Enrollment
692 (estimated)
Sites
109

Conditions

As the registry lists them; a condition with its own page is linked.

chronic idiopathic constipation (cic)